Eicosapentaenoic and docosahexaenoic acids attenuate hyperglycemia through the microbiome-gut-organs axis in db/db mice

BACKGROUND: Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have been suggested to prevent the development of metabolic disorders. However, their individual role in treating hyperglycemia and the mechanism of action regarding gut microbiome and metabolome in the context of diabetes remain...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Pan, Li, Haoyu, Jia, Wei, Shou, Qiyang, Zhu, Ya’er, Mao, Lei, Wang, Wenqiao, Wu, Fei, Chen, Xiaoqian, Wan, Xuzhi, Wu, Yuqi, Liu, Xiaohui, Li, Yin, Zhu, Fanghuan, He, Lilin, Chen, Jingnan, Zhang, Yu, Jiao, Jingjing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434703/
https://www.ncbi.nlm.nih.gov/pubmed/34507608
http://dx.doi.org/10.1186/s40168-021-01126-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434703/
https://www.ncbi.nlm.nih.gov/pubmed/34507608
http://dx.doi.org/10.1186/s40168-021-01126-6

Ejemplares similares